Francis Capital Management LLC 13D and 13G filings for Aridis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 2:09 pm Sale |
2021-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Francis Capital Management LLC | 142,838 1.000% |
-534,021![]() (-78.90%) |
Filing |
2021-04-01 4:50 pm Purchase |
2021-03-17 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Francis Capital Management LLC | 676,859 6.100% |
676,859![]() (New Position) |
Filing |